Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study

[1]  P. Schrauwen,et al.  Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes , 2022, Nutrition & Diabetes.

[2]  Matthew J. Maiden,et al.  Diabetes mellitus, glycaemic control, and severe COVID-19 in the Australian critical care setting: A nested cohort study , 2022, Australian Critical Care.

[3]  Vijay P. Singh,et al.  Evidence showing lipotoxicity worsens outcomes in covid-19 patients and insights about the underlying mechanisms , 2022, iScience.

[4]  M. Soto,et al.  Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients , 2022, Cells.

[5]  M. Dimopoulos,et al.  Diabetes and COVID-19; A Bidirectional Interplay , 2022, Frontiers in Endocrinology.

[6]  Qi Chen,et al.  GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia , 2022, Nature Metabolism.

[7]  G. Van den Berghe,et al.  Hyperglycemia and insulin resistance in COVID-19 versus non-COVID critical illness: Are they really different? , 2021, Critical Care.

[8]  L. Piemonti,et al.  No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection , 2021, The Journal of clinical endocrinology and metabolism.

[9]  K. Khunti,et al.  COVID-19, Hyperglycemia, and New-Onset Diabetes , 2021, Diabetes Care.

[10]  Evan T. Sholle,et al.  Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2 , 2021, Cell Metabolism.

[11]  S. McClave,et al.  Prolonged progressive hypermetabolism during COVID-19 hospitalization undetected by common predictive energy equations , 2021, Clinical Nutrition ESPEN.

[12]  T. Welsch,et al.  Energy requirements of long-term ventilated COVID-19 patients with resolved SARS-CoV-2 infection , 2021, Clinical Nutrition ESPEN.

[13]  J. Bonventre,et al.  Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection , 2021, Nature Metabolism.

[14]  W. Shen,et al.  COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective Study , 2021, Endocrine Practice.

[15]  J. Olieman,et al.  Energy expenditure and feeding practices and tolerance during the acute and late phase of critically ill COVID-19 patients , 2021, Clinical Nutrition ESPEN.

[16]  A. Stenzinger,et al.  SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas , 2021, Nature Metabolism.

[17]  M. S. Kirkman,et al.  The Linearized Disposition Index Augments Understanding of Treatment Effects in Diabetes. , 2020, American journal of physiology. Endocrinology and metabolism.

[18]  P. Zimmet,et al.  Proportion of newly diagnosed diabetes in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Diabetes, obesity & metabolism.

[19]  M. Roden,et al.  Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis , 2020, Diabetologia.

[20]  M. Hayden.  An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms , 2020, Cells.

[21]  A. Davalli,et al.  Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study , 2020, Diabetologia.

[22]  L. Boerger,et al.  Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19 , 2020, Critical Care.

[23]  A. Hartman,et al.  Hypermetabolism and Coronavirus Disease 2019 , 2020, JPEN. Journal of parenteral and enteral nutrition.

[24]  S. McClave,et al.  Nutrition Therapy in Critically Ill Patients With Coronavirus Disease 2019 , 2020, JPEN. Journal of parenteral and enteral nutrition.

[25]  Heng Fan,et al.  Diabetes is a risk factor for the progression and prognosis of COVID‐19 , 2020, Diabetes/metabolism research and reviews.

[26]  G. Rutter,et al.  Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion , 2017, Diabetes.

[27]  P. Tůma,et al.  Rapid determination of branched chain amino acids in human blood plasma by pressure‐assisted capillary electrophoresis with contactless conductivity detection , 2015, Electrophoresis.

[28]  Konstantinos Makris,et al.  Is There a Relationship between Mean Blood Glucose and Glycated Hemoglobin? , 2011, Journal of diabetes science and technology.

[29]  S. McClave,et al.  Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). , 2009, JPEN. Journal of parenteral and enteral nutrition.

[30]  B. Rodrigues,et al.  Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.

[31]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[32]  D. Matthews,et al.  Effect of cortisol on energy expenditure and amino acid metabolism in humans. , 1995, The American journal of physiology.

[33]  M. Mifflin,et al.  A new predictive equation for resting energy expenditure in healthy individuals. , 1990, The American journal of clinical nutrition.

[34]  E. Ferrannini.  The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[35]  J E Frijters,et al.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies. , 1982, The American journal of clinical nutrition.